Related Experiment Videos
Economic issues in coronary heart disease prevention
1School of Postgraduate Medicine, University of Bath, Royal United Hospital, UK.
Current Opinion in Lipidology
|December 1, 1996
Summary
New statin studies show cholesterol lowering is cost-effective for preventing coronary heart disease. This applies to secondary prevention and primary prevention in high-risk individuals with additional risk factors.
Area of Science:
- Cardiovascular Medicine
- Health Economics
Background:
- Cholesterol lowering treatments are effective but face increasing cost-effectiveness challenges.
- Financial pressures on healthcare systems necessitate efficient interventions.
Purpose of the Study:
- To evaluate the cost-effectiveness of new statin therapies.
- To determine the economic value of statins in secondary and primary coronary heart disease prevention.
Main Methods:
- Prospective analysis of new statin studies.
- Cost-effectiveness modeling for different patient risk profiles.
Main Results:
- Secondary prevention of coronary heart disease with statins is consistently cost-effective.
- Primary prevention using statins is cost-effective in individuals with elevated risk and additional risk factors.
Conclusions:
- Statin therapy offers significant cost-effective benefits for coronary heart disease prevention.
- Targeted primary prevention in high-risk groups enhances the economic value of statins.